Skip to main content

Glucagonoma

  • Chapter
Surgical Oncology
  • 261 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Becker SW, Kahn D, Rothman S. Cutaneous manifestations of internal malignant tumors. Arch Dermatol Syphilol 1942;45:1069–1080.

    Google Scholar 

  2. McGavran MH, Unger RH, Recant L, Polk HC, Kilo C, Levin ME. A glucagon-secreting alpha cell carcinoma of the pancreas. N Engl J Med 1966;274:1408–1413.

    Article  CAS  PubMed  Google Scholar 

  3. Mallinson GN, Bloom SR, Warin AP, Salmon PR, Cox B. A glucagonoma syndrome. Lancet 1974;2:1–5.

    Article  CAS  PubMed  Google Scholar 

  4. Sabel MS, Prinz RA. Glucagonoma. Surg Dis Pancreas 1998;79:745–756.

    Google Scholar 

  5. Van Heerden FA, Thompson GB. Islet cell tumours of the pancreas. Surg Pancreas 1993;49:545–561.

    Google Scholar 

  6. Joyce CD, Prinz RA. The glucagonoma syndrome. Probl Gen Surg 1994;11:1–16.

    Google Scholar 

  7. Howard JH, Stabile BE, Zinner MJ, Chang S, Belur BS, Passero E. Anatomic distribution of pancreatic endocrine tumors. Am J Surg 1990;159:258–264.

    CAS  PubMed  Google Scholar 

  8. Prinz RA, Badrinath K, Banerji M, Sparagana M, Dorsch TR, Lawrence AM. Operative and chemotherapeutic management of malignant glucagons-producing tumors. Surgery 1981;90:713–719.

    CAS  PubMed  Google Scholar 

  9. Bloom SR, Polak JM. Glucagonoma syndrome. Am J Med 1987;82(suppl):25–36.

    Article  CAS  PubMed  Google Scholar 

  10. Fujita J, Seino Y, Ishida H, et al. A functional study of a case of glucagonoma exhibiting typical glucagonoma syndrome. Cancer 1986;57:860–865.

    CAS  PubMed  Google Scholar 

  11. Norton JA, Hahn CR, Schiebinger R, et al. Amino acid deficiency and the skin rash associated with glucagonoma. Ann Intern Med 1979;91:213–215.

    CAS  PubMed  Google Scholar 

  12. Naets JP, Guns M. Inhibitory effect of glucagon on erythropoiesis. Blood 1980;55:997–1002.

    CAS  PubMed  Google Scholar 

  13. Wawrukiewicz AS, Rosch J, Keller FS, Lieberman DA. Glucagonoma and its angiographic diagnosis. Cardiovasc Intervent Radiol 1982;5:318–324.

    CAS  PubMed  Google Scholar 

  14. Cho KJ, Wilcox CW, Reuter SR. Glucagon producing islet cell tumor of the pancreas. AJR Am J Roentgenol 1977;145:509–516.

    Google Scholar 

  15. Ingemansson S, Holst J, Larsson LI, et al. Localization of glucagonomas by catheterization of the pancreatic veins and with glucagon assay. Surg Gynecol Obstet 1977;145:509–516.

    CAS  PubMed  Google Scholar 

  16. Rosch T, Lightdale CJ, Botet JF. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med 1992;326:1721–1726.

    Article  CAS  PubMed  Google Scholar 

  17. Krenning EP, Kwekkeboom DJ, Oei HY, et al. Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. Ann NY Acad Sci 1994;773:416–424.

    Google Scholar 

  18. Bilchik AJ, Sarantou T, Foshag L, Giuliano AE, Ramming KP. Cryosurgical palliation of metastatic neuroendocrine tumors resistant to conventional therapy. Surgery 1997;122:1040–1048.

    Article  CAS  PubMed  Google Scholar 

  19. Modlin JM, Lewis JJ, Ahlman H, Bilchik AJ, Jumar RR. Management of unresectable malignant endocrine tumors of the pancreas. Surg Gynecol Obstet 1993;176:507–518.

    CAS  PubMed  Google Scholar 

  20. Moertel CG. An Odyssey in the land of small tumors. J Clin Oncol 1987;5:1503–1522.

    Google Scholar 

  21. Altimari AF, Bhoopalam N, Prinz RA, et al. Use of a somatostatin analog (SMS201-995) in the glucagonoma syndrome. Surgery 1986;100:989–996.

    CAS  PubMed  Google Scholar 

  22. Carrasco D, Jackson NA, Samaan R, et al. The carcinoid syndrome: palliation by hepatic arterial embolization. Am J Radiol 1986;147:149–154.

    CAS  Google Scholar 

  23. Hajarizadeh H, Ivancev K, Mueller CR, et al. Effective palliative treatment of metastatic carcinoid tumors with intra-arterial chemotherapy/chemoembolization combined with octreotide acetate. Am J Surg 1992;163:479–483.

    Article  CAS  PubMed  Google Scholar 

  24. Perry JL, Stuart K, Stokes KR, Clouse ME. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Surgery 1994;116:1116–1117.

    Google Scholar 

  25. Urszniewski P, Rougier P, Roche A, et al. Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors: a prospective phase II study in 24 patients. Cancer 1993;71:2624–2630.

    Google Scholar 

  26. Jockenhovel F, Lederbogen S, Olbricht T, et al. The long-acting somatostatin analogue octreotide alleviates symptoms by reducing post-translational conversion of preproglucagon to glucagon in a patient with malignant glucagonoma, but does not prevent tumor growth. Clin Invest 1994;72:127–133.

    CAS  Google Scholar 

  27. Moertel C, Hauley J, Johnson L. Streptozotocin alone compared with streptozotocin plus fluorouracil in the treatment of advanced islet cell carcinoma. N Engl J Med 1980;303:1189–1194.

    Article  CAS  PubMed  Google Scholar 

  28. Broder LE, Carter SK. Pancreatic islet cell carcinoma: results of therapy with streptozotocin in 52 patients. Ann Intern Med 1973;79:101–107.

    CAS  PubMed  Google Scholar 

  29. Kessinger A, Floley JF, Lemon HM. Therapy of malignant APUD cell tumors: effectiveness of DTIC. Cancer 1983;51:790–794.

    CAS  PubMed  Google Scholar 

  30. Jones DV Jr, Samaan NA, Sellin RV, et al. Metastatic glucagonoma: clinical response to a combination of 5-FU and alpha-interferon. Am J Med 1992;93:348–349.

    Article  PubMed  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag New York, Inc.

About this chapter

Cite this chapter

Talamonti, M.S. (2003). Glucagonoma. In: Saclarides, T.J., Millikan, K.W., Godellas, C.V. (eds) Surgical Oncology. Springer, New York, NY. https://doi.org/10.1007/0-387-21701-0_15

Download citation

  • DOI: https://doi.org/10.1007/0-387-21701-0_15

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-95201-7

  • Online ISBN: 978-0-387-21701-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics